Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Mar-24 5:00 PM View:  | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 06-Mar-24 | Option Sale | 8,104 | $558.44 | $4,525,600.00 | (43%) 18.82K to 10.71K | |
| 07-Mar-24 5:00 PM View: | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 06-Mar-24 | Option Exercise | 8,104 | $422.45 | $3,423,550.00 | 76% 10.71K to 18.82K | |
| 07-Mar-24 5:00 PM View: | Vandebroek Sophie V. Director | IDEXX Laboratories Inc. (IDXX) | 05-Mar-24 | Option Exercise | 1,404 | $245.79 | $345,089.00 | 15% 9.39K to 10.79K | |
| 07-Mar-24 5:00 PM View: | Vandebroek Sophie V. Director | IDEXX Laboratories Inc. (IDXX) | 05-Mar-24 | Option Sale | 1,404 | $562.98 | $790,427.00 | (13%) 10.79K to 9.39K | |
| 04-Mar-24 5:20 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 29-Feb-24 | Gift | 550 | -- | -- | (< 1%) 82.05K to 81.5K | |
| 22-Feb-24 5:02 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 21-Feb-24 | Option Exercise | 483 | $206.94 | $99,952.00 | < 1% 81.56K to 82.05K | |
| 20-Feb-24 5:01 PM View: | Underberg Sharon E. EVP, GC & Corporate Secretary | IDEXX Laboratories Inc. (IDXX) | 16-Feb-24 | Option Exercise | 483 | $206.94 | $99,952.00 | 9% 5.11K to 5.59K | |
| 20-Feb-24 5:00 PM View: | McKeon Brian P EVP, CFO and Treasurer | IDEXX Laboratories Inc. (IDXX) | 15-Feb-24 | Option Exercise | 483 | $206.94 | $99,952.00 | < 1% 48.4K to 48.88K | |
| 16-Feb-24 5:56 PM View: | Lane Michael Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 939 | -- | -- | 15% 6.38K to 7.32K | |
| 16-Feb-24 5:57 PM View: | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 279 | $560.56 | $156,396.00 | (3%) 10.99K to 10.71K | |
| 16-Feb-24 5:57 PM View: | McKeon Brian P EVP, CFO and Treasurer | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 1,731 | -- | -- | 4% 47.77K to 49.5K | |
| 16-Feb-24 5:58 PM View: | Smith Martin Alexander Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 108 | $560.56 | $60,540.50 | (19%) 0.58K to 0.47K | |
| 16-Feb-24 5:55 PM View: | Fennell George SVP, Chief Revenue Officer | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 162 | $560.56 | $90,810.70 | (2%) 7.08K to 6.92K | |
| 16-Feb-24 5:55 PM View: | Hunt Nimrata Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 263 | $560.56 | $147,427.00 | (2%) 12.1K to 11.84K | |
| 16-Feb-24 5:56 PM View: | Johnson Michael Perkins EVP and CHRO | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 60 | $560.56 | $33,633.60 | (25%) 0.24K to 0.18K | |
| 16-Feb-24 5:56 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 1,839 | $560.56 | $1,030,870.00 | (2%) 83.4K to 81.56K | |
| 16-Feb-24 5:56 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 4,156 | -- | -- | 5% 79.25K to 83.4K | |
| 16-Feb-24 5:57 PM View: | McKeon Brian P EVP, CFO and Treasurer | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 1,097 | $560.56 | $614,934.00 | (2%) 49.5K to 48.4K | |
| 16-Feb-24 5:57 PM View: | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 927 | -- | -- | 9% 10.06K to 10.99K | |
| 16-Feb-24 5:58 PM View: | Underberg Sharon E. EVP, GC & Corporate Secretary | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Grant | 1,186 | -- | -- | 28% 4.28K to 5.47K | |
| 16-Feb-24 5:58 PM View: | Smith Martin Alexander Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 337 | -- | -- | 137% 0.25K to 0.58K | |
| 16-Feb-24 5:54 PM View: | Erickson Michael G Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 144 | $560.56 | $80,720.60 | (1%) 10.8K to 10.66K | |
| 16-Feb-24 5:55 PM View: | Hunt Nimrata Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 664 | -- | -- | 6% 11.44K to 12.1K | |
| 16-Feb-24 5:58 PM View: | Schreck Michael Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 117 | $560.56 | $65,585.50 | (13%) 0.9K to 0.79K | |
| 16-Feb-24 5:56 PM View: | Johnson Michael Perkins EVP and CHRO | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 176 | -- | -- | 263% 67 to 0.24K | |
| 16-Feb-24 5:56 PM View: | Lane Michael Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 283 | $560.56 | $158,638.00 | (4%) 7.32K to 7.04K | |
| 16-Feb-24 5:58 PM View: | Underberg Sharon E. EVP, GC & Corporate Secretary | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Payment of Exercise | 356 | $560.56 | $199,559.00 | (7%) 5.47K to 5.11K | |
| 16-Feb-24 5:54 PM View: | Erickson Michael G Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 462 | -- | -- | 4% 10.34K to 10.8K | |
| 16-Feb-24 5:55 PM View: | Hunt Nimrata Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Grant | 208 | -- | -- | 2% 11.23K to 11.44K | |
| 16-Feb-24 5:55 PM View: | Fennell George SVP, Chief Revenue Officer | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 370 | -- | -- | 6% 6.71K to 7.08K | |
| 16-Feb-24 5:58 PM View: | Schreck Michael Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 14-Feb-24 | Option Exercise | 368 | -- | -- | 69% 0.54K to 0.9K | |
| 12-Feb-24 5:03 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 09-Feb-24 | Gift | 5,350 | -- | -- | (< 1%) 582.92K to 577.57K | |
| 09-Feb-24 5:02 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 08-Feb-24 | Gift | 850 | -- | -- | (< 1%) 583.77K to 582.92K | |
| 09-Feb-24 5:03 PM View: | Fennell George SVP, Chief Revenue Officer | IDEXX Laboratories Inc. (IDXX) | 08-Feb-24 | Option Sale | 8,198 | $573.87 | $4,704,560.00 | (55%) 14.91K to 6.71K | |
| 09-Feb-24 5:03 PM View: | Fennell George SVP, Chief Revenue Officer | IDEXX Laboratories Inc. (IDXX) | 08-Feb-24 | Option Exercise | 9,810 | $62.00 | $608,220.00 | 192% 5.1K to 14.91K | |
| 09-Feb-24 5:00 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 07-Feb-24 | Option Exercise | 12,000 | $67.85 | $814,200.00 | 15% 79.25K to 91.25K | |
| 09-Feb-24 5:00 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 07-Feb-24 | Option Sale | 12,000 | $572.61 | $6,871,320.00 | (13%) 91.25K to 79.25K | |
| 09-Feb-24 5:02 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 07-Feb-24 | Gift | 1,000 | -- | -- | (< 1%) 584.77K to 583.77K | |
| 09-Feb-24 5:01 PM View: | McKeon Brian P EVP, CFO and Treasurer | IDEXX Laboratories Inc. (IDXX) | 07-Feb-24 | Option Exercise | 23,326 | $141.60 | $3,302,960.00 | 49% 47.77K to 71.09K | |
| 09-Feb-24 5:01 PM View: | McKeon Brian P EVP, CFO and Treasurer | IDEXX Laboratories Inc. (IDXX) | 07-Feb-24 | Option Sale | 23,326 | $570.01 | $13,296,000.00 | (33%) 71.09K to 47.77K | |
| 01-Feb-24 5:00 PM View: | Junius Daniel M Director | IDEXX Laboratories Inc. (IDXX) | 30-Jan-24 | Grant | 14 | $521.03 | $7,294.42 | < 1% 3.03K to 3.04K | 7% |
| 08-Dec-23 5:00 PM View: | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 07-Dec-23 | Option Exercise | 11,636 | $253.92 | $2,954,640.00 | 116% 10.05K to 21.69K | |
| 08-Dec-23 5:00 PM View: | Polewaczyk James F Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 07-Dec-23 | Option Sale | 11,636 | $521.79 | $6,071,500.00 | (54%) 21.69K to 10.05K | |
| 06-Dec-23 5:00 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 04-Dec-23 | Gift | 2,424 | -- | -- | (< 1%) 587.2K to 584.77K | |
| 06-Dec-23 5:01 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 04-Dec-23 | Option Exercise | 13,424 | $79.54 | $1,067,740.00 | 18% 72.94K to 86.36K | |
| 06-Dec-23 5:01 PM View: | Mazelsky Jay President and CEO Director | IDEXX Laboratories Inc. (IDXX) | 04-Dec-23 | Option Sale | 7,128 | $513.05 | $3,657,050.00 | (8%) 86.36K to 79.23K | |
| 01-Dec-23 5:00 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 29-Nov-23 | Gift | 1,850 | -- | -- | (< 1%) 589.05K to 587.2K | |
| 22-Nov-23 5:00 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 20-Nov-23 | Gift | 2,506 | -- | -- | (< 1%) 591.55K to 589.05K | |
| 16-Nov-23 6:50 PM View: | Ayers Jonathan W Director | IDEXX Laboratories Inc. (IDXX) | 15-Nov-23 | Gift | 2,494 | -- | -- | (< 1%) 594.05K to 591.55K | |
| 08-Nov-23 5:09 PM View: | Lane Michael Executive Vice President | IDEXX Laboratories Inc. (IDXX) | 07-Nov-23 | Option Exercise | 1,728 | $133.76 | $231,142.00 | 37% 4.64K to 6.37K |
